Cargando…

Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial

BACKGROUND: The Trachyspermum ammi L. (TA), Anethum graveolens L. (AG), and Zataria multiflora Boiss (ZM) herbal oils are among the most used herbal products in traditional medicine as the antiseptic, anesthetic, carminative, and antispasmodic. However, there are no clinical studies to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordbar, Ghasem, Miri, Mohammad Bagher, Omidi, Mahmoud, Shoja, Saeed, Akhavan, Malihe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683154/
https://www.ncbi.nlm.nih.gov/pubmed/33273914
http://dx.doi.org/10.1155/2020/5152736
_version_ 1783612818352766976
author Bordbar, Ghasem
Miri, Mohammad Bagher
Omidi, Mahmoud
Shoja, Saeed
Akhavan, Malihe
author_facet Bordbar, Ghasem
Miri, Mohammad Bagher
Omidi, Mahmoud
Shoja, Saeed
Akhavan, Malihe
author_sort Bordbar, Ghasem
collection PubMed
description BACKGROUND: The Trachyspermum ammi L. (TA), Anethum graveolens L. (AG), and Zataria multiflora Boiss (ZM) herbal oils are among the most used herbal products in traditional medicine as the antiseptic, anesthetic, carminative, and antispasmodic. However, there are no clinical studies to evaluate the efficacy of the herbs mentioned in the treatment of functional dyspepsia (FD). This study was designed to appraise the efficacy and safety of a novel herbal medicine consisting of ZM, AG, and TA essential oils compared to omeprazole in FD treatment. METHODS: The present study was a randomized double-blind clinical trial with parallel groups in Iran. Patients in control and intervention arms received omeprazole 20 mg once a day and 250 mg soft-gel capsules containing 180 mg of essential oils of ZM, AG, and TA twice a day for two weeks, respectively. The primary outcome was the sufficient response rate in the postprandial distress syndrome (PDS) and/or epigastric pain syndrome (EPS) at the end of the intervention. Secondary outcomes were the improvement rate in the PDS, EPS, Gastrointestinal Symptom Rating Scale (GSRS), and quality of life scores. Also, safety and tolerability were assessed. RESULTS: The within-group comparison of EPS, PDS, total GSRS, GSRS Pain, and GSRS Dyspepsia scores with that at the end of the treatment indicated a significant reduction in both control and intervention groups (p < 0.001). However, after two weeks of treatment, the herbal medication and omeprazole arms were significantly different in the sufficient response rate based on PDS (p < 0.01) and EPS (p < 0.05) scores (78.3% (18/23) and 73.7% (14/19) in the intervention group vs. 36.4% (8/22) and 40.9% (9/22) in the control group). Also, the mean reduction in EPS (p < 0.05), PDS (p < 0.01), and GSRS (p < 0.001) scores after treatment was significantly higher in the intervention group than control group. CONCLUSION: Based on the study findings, this herbal medicine can be considered as an appropriate treatment of FD. However, a larger multicenter trial is needed to confirm the results of the trial.
format Online
Article
Text
id pubmed-7683154
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76831542020-12-02 Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial Bordbar, Ghasem Miri, Mohammad Bagher Omidi, Mahmoud Shoja, Saeed Akhavan, Malihe Gastroenterol Res Pract Research Article BACKGROUND: The Trachyspermum ammi L. (TA), Anethum graveolens L. (AG), and Zataria multiflora Boiss (ZM) herbal oils are among the most used herbal products in traditional medicine as the antiseptic, anesthetic, carminative, and antispasmodic. However, there are no clinical studies to evaluate the efficacy of the herbs mentioned in the treatment of functional dyspepsia (FD). This study was designed to appraise the efficacy and safety of a novel herbal medicine consisting of ZM, AG, and TA essential oils compared to omeprazole in FD treatment. METHODS: The present study was a randomized double-blind clinical trial with parallel groups in Iran. Patients in control and intervention arms received omeprazole 20 mg once a day and 250 mg soft-gel capsules containing 180 mg of essential oils of ZM, AG, and TA twice a day for two weeks, respectively. The primary outcome was the sufficient response rate in the postprandial distress syndrome (PDS) and/or epigastric pain syndrome (EPS) at the end of the intervention. Secondary outcomes were the improvement rate in the PDS, EPS, Gastrointestinal Symptom Rating Scale (GSRS), and quality of life scores. Also, safety and tolerability were assessed. RESULTS: The within-group comparison of EPS, PDS, total GSRS, GSRS Pain, and GSRS Dyspepsia scores with that at the end of the treatment indicated a significant reduction in both control and intervention groups (p < 0.001). However, after two weeks of treatment, the herbal medication and omeprazole arms were significantly different in the sufficient response rate based on PDS (p < 0.01) and EPS (p < 0.05) scores (78.3% (18/23) and 73.7% (14/19) in the intervention group vs. 36.4% (8/22) and 40.9% (9/22) in the control group). Also, the mean reduction in EPS (p < 0.05), PDS (p < 0.01), and GSRS (p < 0.001) scores after treatment was significantly higher in the intervention group than control group. CONCLUSION: Based on the study findings, this herbal medicine can be considered as an appropriate treatment of FD. However, a larger multicenter trial is needed to confirm the results of the trial. Hindawi 2020-11-12 /pmc/articles/PMC7683154/ /pubmed/33273914 http://dx.doi.org/10.1155/2020/5152736 Text en Copyright © 2020 Ghasem Bordbar et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bordbar, Ghasem
Miri, Mohammad Bagher
Omidi, Mahmoud
Shoja, Saeed
Akhavan, Malihe
Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial
title Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial
title_full Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial
title_fullStr Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial
title_full_unstemmed Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial
title_short Comparison of a Novel Herbal Medicine and Omeprazole in the Treatment of Functional Dyspepsia: A Randomized Double-Blinded Clinical Trial
title_sort comparison of a novel herbal medicine and omeprazole in the treatment of functional dyspepsia: a randomized double-blinded clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683154/
https://www.ncbi.nlm.nih.gov/pubmed/33273914
http://dx.doi.org/10.1155/2020/5152736
work_keys_str_mv AT bordbarghasem comparisonofanovelherbalmedicineandomeprazoleinthetreatmentoffunctionaldyspepsiaarandomizeddoubleblindedclinicaltrial
AT mirimohammadbagher comparisonofanovelherbalmedicineandomeprazoleinthetreatmentoffunctionaldyspepsiaarandomizeddoubleblindedclinicaltrial
AT omidimahmoud comparisonofanovelherbalmedicineandomeprazoleinthetreatmentoffunctionaldyspepsiaarandomizeddoubleblindedclinicaltrial
AT shojasaeed comparisonofanovelherbalmedicineandomeprazoleinthetreatmentoffunctionaldyspepsiaarandomizeddoubleblindedclinicaltrial
AT akhavanmalihe comparisonofanovelherbalmedicineandomeprazoleinthetreatmentoffunctionaldyspepsiaarandomizeddoubleblindedclinicaltrial